>>> US Gapping down

Gapping down
In reaction to earnings/guidance:
  • TBI -18%, HCA -9.1%, HXL -7.4%, AGNC -7.3% (prelim Q3 estimates), PII -6.3%, AAN -5.6%, HOUS -5.3%, BCS -5.1%, TRU -4.4%, GLW -4%, CALX -2.6%, CDNS -2.5%, SPOT -2.5%, PKG -2.1%, ABG -2.1%, CCK -2%, TFII -1.3%, NVS -0.8%
Other news:
  • IONQ -12.7% (Co-Founder stepping down)
  • IMTX -4.2% (receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation for ACTengine IMA203 TCR-T monotherapy)
  • SDA -3% (stock offering)
  • SEE -1.5% (CEO stepping down; reiterates guidance; also downgraded to Mkt Perform from Outperform at William Blair)
  • MREO -1.1% (reports on recent program developments)
Analyst comments:
  • MKFG -17.7% (downgraded to Mkt Perform from Outperform at William Blair)
  • FMC -2.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley; downgraded to Neutral from Buy at BofA Securities; downgraded to Neutral from Buy at Goldman)
  • CUBE -1.1% ( downgraded to Equal Weight from Overweight at Wells Fargo)
  • MNST -1% (downgraded to Neutral from Overweight at Piper Sandler)